Literature DB >> 8904669

Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus.

S L Brockmeier1, W L Mengeling.   

Abstract

A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 was administered to pigs to determine if it would have a greater protective effect than a vector containing the gene for gp50 alone. Both NYVAC vectors protected pigs similarly from virulent pseudorabies virus challenge.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8904669      PMCID： PMC1263855     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN： 0830-9000            Impact factor:   1.310


  7 in total

Review 1.  Spread and control of Aujeszky's disease (AD).

Authors:  G Wittmann
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1991       Impact factor: 2.268

2.  NYVAC: a highly attenuated strain of vaccinia virus.

Authors:  J Tartaglia; M E Perkus; J Taylor; E K Norton; J C Audonnet; W I Cox; S W Davis; J van der Hoeven; B Meignier; M Riviere
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

Review 3.  Molecular biology of pseudorabies (Aujeszky's disease) virus.

Authors:  T C Mettenleiter
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1991       Impact factor: 2.268

4.  Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus.

Authors:  W L Mengeling
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.

Authors:  W L Mengeling; S L Brockmeier; K M Lager
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.

Authors:  S L Brockmeier; K M Lager; J Tartaglia; M Riviere; E Paoletti; W L Mengeling
Journal:  Vet Microbiol       Date:  1993-12       Impact factor: 3.293

7.  Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.

Authors:  M Riviere; J Tartaglia; M E Perkus; E K Norton; C M Bongermino; F Lacoste; C Duret; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103
  7 in total
  2 in total

1.  Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.

Authors:  José Luis Nájera; Carmen Elena Gómez; Elena Domingo-Gil; María Magdalena Gherardi; Mariano Esteban
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 2.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.